The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

Saved in:
Bibliographic Details
Published inLeukemia Vol. 29; no. 9; pp. 1952 - 1954
Main Authors Coles, S J, Gilmour, M N, Reid, R, Knapper, S, Burnett, A K, Man, S, Tonks, A, Darley, R L
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2015
Nature Publishing Group
Subjects
13/106
13/31
45/61
631/67/580
Acute myelocytic leukemia
Antigens, CD - genetics
Antigens, CD - metabolism
B7-H1 Antigen - genetics
B7-H1 Antigen - metabolism
Cancer Research
Care and treatment
CD200 antigen
Cellular proteins
Cloning
Critical Care Medicine
Gene expression
Genetic aspects
Health aspects
Hematology
Humans
Immune response
Immunology
Immunosuppression
Immunosuppressive agents
Immunotherapy
Intensive
Internal Medicine
letter-to-the-editor
Letters to the editor
Leukemia
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - immunology
Leukemia, Myeloid, Acute - metabolism
Leukemia, Myeloid, Acute - therapy
Ligands
Ligands (Biochemistry)
Lymphocytes
Lymphocytes T
Medicine
Medicine & Public Health
Methods
Oncology
Patient outcomes
Patients
PD-L1 protein
Protein expression
Proteins
T cells
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
T-Lymphocytes - pathology
United Kingdom
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2015.62